Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Immuno-Grade Bombesin Receptor 2 Antibodies

Close filters
No results were found for the filter!
Citations
Immunohistochemical identification of Bombesin Receptor 2/Gastrin-Relasing Peptide Receptor (BB2/GRPR) in human breast carcinoma.
BB2 (IHC-grade), Bombesin Receptor...
The BB2/GRPR receptor antibody is directed against the distal end of the carboxyl-terminal tail of human Bombesin Receptor 2 (previously called Gastrin-Releasing Peptide Receptor). It can be used to detect total BB2 receptors in Western...
$ 375.00 *

BB2 (also called GRPR) is the specific receptor for gastrin-releasing peptide (GRP). BB2 signals via association with Gq proteins. BB2 is widely distributed in the CNS and peripheral tissues. Activation of BB2 receptors causes a wide range of physiological actions, including the stimulation of smooth-muscle contraction, feeding behavior and secretion. BB2 also contributes to the perception of prurient stimuli and transmission of itch signals in the spinal cord that promote scratching behavior. BB2 is also expressed in neoplastic tissues including breast, prostate and pancreatic carcinomas.

BB2 (also called GRPR) is the specific receptor for gastrin-releasing peptide (GRP). BB2 signals via association with Gq proteins. BB2 is widely distributed in the CNS and peripheral tissues.... read more »
Close window
Immuno-Grade Bombesin Receptor 2 Antibodies

BB2 (also called GRPR) is the specific receptor for gastrin-releasing peptide (GRP). BB2 signals via association with Gq proteins. BB2 is widely distributed in the CNS and peripheral tissues. Activation of BB2 receptors causes a wide range of physiological actions, including the stimulation of smooth-muscle contraction, feeding behavior and secretion. BB2 also contributes to the perception of prurient stimuli and transmission of itch signals in the spinal cord that promote scratching behavior. BB2 is also expressed in neoplastic tissues including breast, prostate and pancreatic carcinomas.

Recently viewed